SEC reporting owner

LaBrosse Nicole SEC insider disclosures

Explore LaBrosse Nicole's reporting-owner identity, issuer relationships, purchases, sales and SEC filing receipts.

As of 2026-10-07T00:29:11.873Z

Reporting owner CIK
0001910662
Issuers
1
Coverage
verified

Issuer relationships

A reporting-owner CIK identifies the filer across issuer relationships and name aliases. A filer may be an individual or an organization; the filing role is the relevant evidence.

HALOZYME THERAPEUTICS, INC.0001159036HALOYesNo

Recent SEC transactions

Code P identifies a purchase, S a sale and A an award. Awards and open-market purchases describe different events. Use the public availability date when deciding when a researcher could have known about the transaction.

2026-02-122026-02-09HALOA29,502Not reported
2026-02-122026-02-09HALOA7,448Not reported
2026-02-122026-02-09HALOA5,167Not reported
2025-09-242025-09-22HALOS314Not reported
2025-09-242025-09-22HALOS1,913Not reported
2025-09-122025-09-10HALOS13,240Not reported
2025-09-122025-09-10HALOS6,760Not reported
2025-02-222025-02-20HALOA21,327Not reported
2025-02-222025-02-20HALOA22,603Not reported
2025-02-152025-02-12HALOA28,662Not reported
2025-02-152025-02-12HALOA6,935Not reported
2025-02-152025-02-12HALOA5,221Not reported
2025-02-152025-02-12HALOA6,050Not reported

Up to 50 transactions from the recent two-year owner window.

Source evidence and strategy eligibility

The transactions below come from filings; a historical tracker separately simulates following eligible events. Joint filers can report the same transaction, and an owner can have filings at multiple companies. Public availability, amendment lineage and verified coverage determine which events a historical tracker may use.

The current directory marks this owner's filing coverage verified.